Funding for this research was provided by:
China Scholarship Council (201906940022)
Received: 29 March 2022
Accepted: 29 July 2022
First Online: 19 September 2022
: The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare, and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; ExternalRef removed) and into the WHO International Clinical Trials Registry Platform (ICTRP; ExternalRef removed) under shared catalog number NTR6831. All participants provided written informed consent to participate in the study and to have their information obtained from their treating physicians.
: Not applicable
: The authors declare that they have no competing interests.